We assign a fundamental rating of 4 out of 10 to JBSS. JBSS was compared to 87 industry peers in the Food Products industry. JBSS has an average financial health and profitability rating. JBSS is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year JBSS was profitable.
JBSS had a positive operating cash flow in the past year.
JBSS had positive earnings in each of the past 5 years.
Each year in the past 5 years JBSS had a positive operating cash flow.

1.2 Ratios

JBSS has a Return On Assets of 11.02%. This is amongst the best in the industry. JBSS outperforms 95.40% of its industry peers.
Looking at the Return On Equity, with a value of 18.19%, JBSS belongs to the top of the industry, outperforming 90.80% of the companies in the same industry.
JBSS has a better Return On Invested Capital (13.93%) than 91.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBSS is significantly below the industry average of 27.79%.

		Industry Rank	Sector Rank
ROA	11.02%
ROE	18.19%
ROIC	13.93%

ROA(3y)12.11%

ROA(5y)13.03%

ROE(3y)18.85%

ROE(5y)20.67%

ROIC(3y)16.04%

ROIC(5y)17.32%

1.3 Margins

The Profit Margin of JBSS (5.84%) is better than 75.86% of its industry peers.
In the last couple of years the Profit Margin of JBSS has declined.
Looking at the Operating Margin, with a value of 8.38%, JBSS is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
JBSS's Operating Margin has declined in the last couple of years.
The Gross Margin of JBSS (18.68%) is comparable to the rest of the industry.
JBSS's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	8.38%
PM (TTM)	5.84%
GM	18.68%

OM growth 3Y-4.93%

OM growth 5Y-3.02%

PM growth 3Y-6.28%

PM growth 5Y-2.84%

GM growth 3Y-4.17%

GM growth 5Y-1.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), JBSS is creating value.
JBSS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, JBSS has more shares outstanding
The debt/assets ratio for JBSS is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 5.56 indicates that JBSS is not in any danger for bankruptcy at the moment.
JBSS has a Altman-Z score of 5.56. This is amongst the best in the industry. JBSS outperforms 87.36% of its industry peers.
JBSS has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
JBSS has a Debt to Equity ratio of 0.22. This is in the better half of the industry: JBSS outperforms 70.11% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	5.56

ROIC/WACC1.6

WACC8.72%

2.3 Liquidity

JBSS has a Current Ratio of 2.44. This indicates that JBSS is financially healthy and has no problem in meeting its short term obligations.
JBSS has a better Current ratio (2.44) than 68.97% of its industry peers.
A Quick Ratio of 0.72 indicates that JBSS may have some problems paying its short term obligations.
With a Quick ratio value of 0.72, JBSS is not doing good in the industry: 63.22% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	2.44
Quick Ratio	0.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.86% over the past year.
JBSS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.37% yearly.
Looking at the last year, JBSS shows a small growth in Revenue. The Revenue has grown by 1.88% in the last year.
Measured over the past years, JBSS shows a small growth in Revenue. The Revenue has been growing by 4.70% on average per year.

EPS 1Y (TTM)20.86%

EPS 3Y-0.91%

EPS 5Y1.37%

EPS Q2Q%59%

Revenue 1Y (TTM)1.88%

Revenue growth 3Y5.02%

Revenue growth 5Y4.7%

Sales Q2Q%8.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y20.37%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year5.4%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.42, JBSS is valued correctly.
Based on the Price/Earnings ratio, JBSS is valued a bit cheaper than the industry average as 72.41% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.32, JBSS is valued rather cheaply.
JBSS is valuated correctly with a Price/Forward Earnings ratio of 12.45.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JBSS indicates a somewhat cheap valuation: JBSS is cheaper than 78.16% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of JBSS to the average of the S&P500 Index (24.30), we can say JBSS is valued slightly cheaper.

		Industry Rank	Sector Rank
PE	13.42
Fwd PE	12.45

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBSS is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.44

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of JBSS may justify a higher PE ratio.

PEG (NY)0.66

PEG (5Y)9.82

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

JBSS has a Yearly Dividend Yield of 1.21%.
JBSS's Dividend Yield is comparable with the industry average which is at 2.28.
Compared to the average S&P500 Dividend Yield of 1.86, JBSS is paying slightly less dividend.

		Industry Rank	Sector Rank
Dividend Yield	1.21%

5.2 History

The dividend of JBSS decreases each year by -19.01%.
JBSS has been paying a dividend for at least 10 years, so it has a reliable track record.

Dividend Growth(5Y)-19.01%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

26.50% of the earnings are spent on dividend by JBSS. This is a low number and sustainable payout ratio.

DP26.5%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (1/21/2026, 8:00:03 PM)

After market: 75.41 0 (0%)

75.41

+0.26 (+0.35%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)10-29 2025-10-29/amc

Earnings (Next)01-27 2026-01-27

Inst Owners95.31%

Inst Owner Change-0.06%

Ins Owners1.44%

Ins Owner Change-14.65%

Market Cap877.77M

Revenue(TTM)1.13B

Net Income(TTM)66.00M

Analysts85.71

Price TargetN/A

Short Float %2.02%

Short Ratio2.82

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.21%

Yearly Dividend2.1

Dividend Growth(5Y)-19.01%

DP26.5%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	13.42
Fwd PE	12.45
P/S	0.78
P/FCF	N/A
P/OCF	16.33
P/B	2.42
P/tB	2.53
EV/EBITDA	7.44

EPS(TTM)5.62

EY7.45%

EPS(NY)6.05

Fwd EY8.03%

FCF(TTM)-0.85

FCFYN/A

OCF(TTM)4.62

OCFY6.12%

SpS97.06

BVpS31.17

TBVpS29.8

PEG (NY)0.66

PEG (5Y)9.82

Graham Number62.78

Profitability

		Industry Rank	Sector Rank
ROA	11.02%
ROE	18.19%
ROCE	20.5%
ROIC	13.93%
ROICexc	13.95%
ROICexgc	14.39%
OM	8.38%
PM (TTM)	5.84%
GM	18.68%
FCFM	N/A

ROA(3y)12.11%

ROA(5y)13.03%

ROE(3y)18.85%

ROE(5y)20.67%

ROIC(3y)16.04%

ROIC(5y)17.32%

ROICexc(3y)16.09%

ROICexc(5y)17.36%

ROICexgc(3y)16.85%

ROICexgc(5y)18.29%

ROCE(3y)22.35%

ROCE(5y)24.36%

ROICexgc growth 3Y-10.55%

ROICexgc growth 5Y-7.62%

ROICexc growth 3Y-10.04%

ROICexc growth 5Y-6.93%

OM growth 3Y-4.93%

OM growth 5Y-3.02%

PM growth 3Y-6.28%

PM growth 5Y-2.84%

GM growth 3Y-4.17%

GM growth 5Y-1.65%

F-Score5

Asset Turnover1.89

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Debt/EBITDA	0.67
Cap/Depr	231.27%
Cap/Sales	5.64%
Interest Coverage	250
Cash Conversion	43.96%
Profit Quality	N/A
Current Ratio	2.44
Quick Ratio	0.72
Altman-Z	5.56

F-Score5

WACC8.72%

ROIC/WACC1.6

Cap/Depr(3y)134.82%

Cap/Depr(5y)127.89%

Cap/Sales(3y)3.1%

Cap/Sales(5y)2.82%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)20.86%

EPS 3Y-0.91%

EPS 5Y1.37%

EPS Q2Q%59%

EPS Next Y20.37%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.88%

Revenue growth 3Y5.02%

Revenue growth 5Y4.7%

Sales Q2Q%8.14%

Revenue Next Year5.4%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y25.64%

EBIT growth 3Y-0.15%

EBIT growth 5Y1.53%

EBIT Next Year58.78%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-110.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-53.67%

OCF growth 3Y15.94%

OCF growth 5Y-13.64%

JOHN B. SANFILIPPO & SON INC / JBSS FAQ

What is the ChartMill fundamental rating of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to JBSS.

Can you provide the valuation status for JOHN B. SANFILIPPO & SON INC?

ChartMill assigns a valuation rating of 5 / 10 to JOHN B. SANFILIPPO & SON INC (JBSS). This can be considered as Fairly Valued.

What is the profitability of JBSS stock?

JOHN B. SANFILIPPO & SON INC (JBSS) has a profitability rating of 6 / 10.

Can you provide the PE and PB ratios for JBSS stock?

The Price/Earnings (PE) ratio for JOHN B. SANFILIPPO & SON INC (JBSS) is 13.42 and the Price/Book (PB) ratio is 2.42.

What is the financial health of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

The financial health rating of JOHN B. SANFILIPPO & SON INC (JBSS) is 4 / 10.